Search Results - "Burr NE"

Letter: efficacy of peppermint oil in irritable bowel syndrome-authors' reply.

Authors: Ingrosso MR Ianiro G Nee J et al.

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Oct; Vol. 56 (7), pp. 1217-1218.

Publication Type: Letter; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome. Authors' reply.

Authors: Goodoory VC Ng CE Black CJ et al.

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Sep; Vol. 56 (5), pp. 894-895.

Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Polyethylene glycol-based laxatives for chronic constipation - Authors' reply.

Authors: Luthra P Camilleri M Burr NE et al.

Source: The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2020 Feb; Vol. 5 (2), pp. 110-111. Date of Electronic Publication: 2020 Jan 08.

Publication Type: Letter; Comment

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101690683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-1253 (Electronic) NLM ISO Abbreviation: Lancet Gastroenterol Hepatol Subsets: MEDLINE

Assessing the efficacy of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the treatment of opioid-induced constipation: authors reply.

Authors: Burr NE Ford AC

Source: Gut [Gut] 2019 Aug; Vol. 68 (8), pp. 1530-1531. Date of Electronic Publication: 2018 Jul 06.

Publication Type: Letter; Comment

Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut

Comprehensive analysis of etrasimod-related adverse events based on the FDA Adverse Event Reporting System database.

Authors: Zhou, Zi-Ru Zhang, Wen-Jia Zhao, Xiao-Yi et al.

Source: Indian Journal of Pharmacology. Jul/Aug2026, Vol. 58 Issue 4, p442-451. 10p.

Editorial: co‐morbid gastrointestinal conditions are an important consideration in IBS management—authors' reply.

Authors: Black, Christopher J. Ford, Alexander C.

Source: Alimentary Pharmacology & Therapeutics. May2021, Vol. 53 Issue 10, p1153-1154. 2p.

Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply.

Authors: Nelson AD Black CJ Houghton LA et al.

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 198-199.

Publication Type: Editorial; Comment

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Optimal use and cycling strategies of Janus kinase inhibitors in ulcerative colitis: current evidence and clinical implications from the KASID Guidelines Task Force Team.

Authors: Hong, Seung Min Kim, Dong Hyun Bae, June Hwa et al.

Source: Intestinal Research. Jan2026, Vol. 24 Issue 1, p27-37. 11p.

Cost calculation model of introducing Upadacitinib and Risankizumab for adult ulcerative colitis and Crohn's disease in the Kingdom of Saudi Arabia.

Authors: Mosli, Mahmoud H. Almutairdi, Abdulelah A. Alshahrani, Abdullah M. et al.

Source: Saudi Journal of Gastroenterology. Jan/Feb2026, Vol. 32 Issue 1, p66-78. 13p.

Immunohistochemical Staining for Disseminated Carcinomatosis of the Bone Marrow in a Patient with Post-Colonoscopy Colorectal Cancer: A Case Report.

Authors: Mochimaru, Tomoaki Kawashima, Kazumasa Onizawa, Michio et al.

Source: Case Reports in Gastroenterology. 2025, Vol. 19 Issue 1, p777-783. 7p.

Propensity score-matched real-world comparative treatment outcomes of Janus kinase inhibitors for ulcerative colitis in patients with and without prior exposure to anti-tumor necrosis factor α antibody.

Authors: Ikenouchi, Maiko Fukui, Hirokazu Yagi, Soichi et al.

Source: Intestinal Research. Oct2025, Vol. 23 Issue 4, p464-474. 11p.

BSG/ACPGBI guidance on the management of colorectal polyps in patients with limited life expectancy.

Authors: Rutter MD Ranjan R Westwood C et al.

Source: Gut [Gut] 2025 Sep 08; Vol. 74 (10), pp. 1551-1560. Date of Electronic Publication: 2025 Sep 08.

Publication Type: Journal Article; Practice Guideline

Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

Construction and Evaluation of Guanylyl Cyclase C–Specific Antibody for Noninvasive Diagnosis and Targeted Therapy of Colorectal Cancer.

Authors: Rong, Zhuona Liu, Hongjin Teng, Xia et al.

Source: Journal of Nuclear Medicine. Mar2026, Vol. 67 Issue 3, p471-480. 10p.

Alcoholic vs. aqueous chlorhexidine for abdominal surgery skin preparation: a randomized controlled trial.

Authors: Sukvibul, Pakkapol Tansawet, Amarit Kultanaruangnonth, Metasist et al.

Source: Scientific Reports. 8/9/2025, Vol. 15 Issue 1, p1-9. 9p.

Gastrointestinal endoscopy for intestinal dysplasia and neoplasia detection and management in Crohn's disease: when and how?

Authors: Pessarelli, Tommaso Piagnani, Alessandra Tontini, Gian Eugenio et al.

Source: Frontiers in Gastroenterology (Frontiers Media S.A.). 2025, p1-8. 8p.

Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY Trial.

Authors: Ma, Christopher Feagan, Brian G Wang, Zhongya et al.

Source: Journal of Crohn's & Colitis. Jan2025, Vol. 19, p1-5. 5p.

Duty of Candour legislation in post-colonoscopy colorectal cancer: a prospective cohort study.

Authors: Saunsbury E Burr NE Beaton D et al.

Source: Endoscopy [Endoscopy] 2025 Apr; Vol. 57 (4), pp. 361-365. Date of Electronic Publication: 2024 Oct 16.

Publication Type: Journal Article

Journal Info: Publisher: Georg Thieme Verlag Country of Publication: Germany NLM ID: 0215166 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1438-8812 (Electronic) Linking ISSN: 0013726X NLM ISO Abbreviation: Endoscopy Subsets: MEDLINE

Comparative Efficacy of Different Targeted Therapies in Patients With Moderate‐to‐Severe Ulcerative Colitis: Systematic Review/Network Meta‐Analysis and Mechanistic Overview.

Authors: Dai, Youran Yang, Wenhui Xu, Li et al.

Source: Pharmacology Research & Perspectives. Jun2025, Vol. 13 Issue 3, p1-16. 16p.

Pharmacological treatment of postoperative recurrence of Crohn's disease: Protocol for systematic review and network meta-analysis.

Authors: Jiang, Tianxiang Cai, Zhaolun Liu, Chunjuan et al.

Source: PLoS ONE. 10/9/2024, Vol. 19 Issue 10, p1-9. 9p.

Successful Remission with Upadacitinib in Two Patients with Anti-TNF-Refractory Macular Edema Associated with Behçet's Uveitis.

Authors: Tao, Tianyu He, Daquan Peng, Xuening et al.

Source: Ocular Immunology & Inflammation. Oct2024, Vol. 32 Issue 8, p1897-1900. 4p.